Love Linnér

451 total citations
14 papers, 350 citations indexed

About

Love Linnér is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Love Linnér has authored 14 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Love Linnér's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Love Linnér is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Love Linnér collaborates with scholars based in Sweden, United Kingdom and United States. Love Linnér's co-authors include Martin Schalling, T.H. Svensson, F. Bengtsson, Daniel Öhman, Torgny H. Svensson, George G. Nomikos, Lotta Arborelius, Leif Bertilsson, Bruno Silvestrini and I Eriksson and has published in prestigious journals such as Gastroenterology, Biological Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Love Linnér

14 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Love Linnér Sweden 9 191 97 66 61 58 14 350
Vasiliki Mitsi United States 9 214 1.1× 152 1.6× 38 0.6× 63 1.0× 80 1.4× 11 471
Maria M Backer Israel 8 147 0.8× 74 0.8× 52 0.8× 40 0.7× 96 1.7× 10 347
G. Chamba France 12 152 0.8× 96 1.0× 37 0.6× 43 0.7× 46 0.8× 33 544
B.L. Jorissen Netherlands 6 104 0.5× 55 0.6× 51 0.8× 84 1.4× 56 1.0× 7 330
Daniel van Kammen United States 6 136 0.7× 53 0.5× 75 1.1× 29 0.5× 41 0.7× 9 268
L. Heikkilä Finland 9 122 0.6× 85 0.9× 88 1.3× 21 0.3× 51 0.9× 16 321
H. Silva Chile 4 83 0.4× 92 0.9× 109 1.7× 55 0.9× 16 0.3× 6 352
M.I. Alaverdyan United States 7 81 0.4× 77 0.8× 23 0.3× 56 0.9× 73 1.3× 10 403
Chih-Ken Chen Taiwan 10 187 1.0× 84 0.9× 183 2.8× 70 1.1× 85 1.5× 13 429
S. Bravin Italy 6 108 0.6× 56 0.6× 79 1.2× 35 0.6× 76 1.3× 10 408

Countries citing papers authored by Love Linnér

Since Specialization
Citations

This map shows the geographic impact of Love Linnér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Love Linnér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Love Linnér more than expected).

Fields of papers citing papers by Love Linnér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Love Linnér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Love Linnér. The network helps show where Love Linnér may publish in the future.

Co-authorship network of co-authors of Love Linnér

This figure shows the co-authorship network connecting the top 25 collaborators of Love Linnér. A scholar is included among the top collaborators of Love Linnér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Love Linnér. Love Linnér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Linnér, Love, et al.. (2021). Post‐stroke epilepsy and antiepileptic drug use in men and women. Basic & Clinical Pharmacology & Toxicology. 129(2). 148–157. 4 indexed citations
2.
Linnér, Love, et al.. (2020). Forecasting drug utilization and expenditure: ten years of experience in Stockholm. BMC Health Services Research. 20(1). 410–410. 18 indexed citations
3.
Fortuny, Joan, Alicia Gilsenan, Miguel Cainzos‐Achirica, et al.. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Safety. 42(10). 1167–1177. 3 indexed citations
4.
Gilsenan, Alicia, Joan Fortuny, Miguel Cainzos‐Achirica, et al.. (2019). Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. Drug Safety. 42(10). 1179–1190. 23 indexed citations
5.
6.
Nilsson, Fredrik, Love Linnér, Eva Samuelsson, & Ian Milsom. (2011). Cost‐effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry. British Journal of Urology. 110(2). 240–246. 11 indexed citations
7.
Linnér, Love, et al.. (2005). Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.. PubMed. 1(3). 253–60. 4 indexed citations
8.
Wadenberg, Marie-Louise G., et al.. (2004). Adjunctive treatment with mianserin enhances raclopride-induced cortical dopamine output and, in parallel, its antipsychotic-like effect.. Neuropsychiatric Disease and Treatment. 1. 253–260. 2 indexed citations
9.
10.
Leone, Maria Grazia, Björn Schilström, Love Linnér, et al.. (2001). Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition. Psychopharmacology. 159(1). 98–104. 38 indexed citations
11.
Johansson, Carolina, Mårten Jansson, Love Linnér, et al.. (2001). Genetics of affective disorders. European Neuropsychopharmacology. 11(6). 385–394. 38 indexed citations
12.
Linnér, Love, et al.. (2001). Reboxetine Modulates the Firing Pattern of Dopamine Cells in the Ventral Tegmental Area and Selectively Increases Dopamine Availability in the Prefrontal Cortex. Journal of Pharmacology and Experimental Therapeutics. 297(2). 540–546. 102 indexed citations
13.
Arborelius, Lotta, et al.. (2000). Partial 5-HT 1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo. Psychopharmacology. 151(1). 77–84. 20 indexed citations
14.
Linnér, Love, Lotta Arborelius, George G. Nomikos, Leif Bertilsson, & Torgny H. Svensson. (1999). Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of α2-adrenoceptor blockade. Biological Psychiatry. 46(6). 766–774. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vasiliki Mitsi Breakdown of academic impact, for papers by Maria M Backer Breakdown of academic impact, for papers by G. Chamba Breakdown of academic impact, for papers by B.L. Jorissen Breakdown of academic impact, for papers by Daniel van Kammen Breakdown of academic impact, for papers by L. Heikkilä Breakdown of academic impact, for papers by H. Silva Breakdown of academic impact, for papers by M.I. Alaverdyan Breakdown of academic impact, for papers by Chih-Ken Chen Breakdown of academic impact, for papers by S. Bravin
Rankless by CCL
2026